Acer Therapeutics Inc

+0.05 (+1.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)45.09M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2 Million
Adjusted EPS-$0.37
See more estimates
10-Day MA$3.00
50-Day MA$2.87
200-Day MA$2.93
See more pivots

Acer Therapeutics Inc Stock, NASDAQ:ACER

One Gateway Center, 300 Washington Street, Newton, Massachusetts 02458
United States of America
Phone: +1.844.902.6100
Number of Employees: 20


Acer Therapeutics, Inc. is a pharmaceutical company. It engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes ACER-001 Edsivo and ACER-2820. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded on March 15, 1991 and is headquartered in Newton, MA.